Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8C3J5

Entry ID Method Resolution Chain Position Source
AF-Q8C3J5-F1 Predicted AlphaFoldDB

83 variants for Q8C3J5

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1132928266 49 L>H No EVA
rs1132577917 52 H>Y No EVA
rs1133651358 53 K>E No EVA
rs3389137363 66 L>I No EVA
rs3389160959 93 T>I No EVA
rs3389088537 103 K>R No EVA
rs3412920802 120 M>I No EVA
rs3389137398 133 S>L No EVA
rs3401440151 141 L>QFLQLILG* No EVA
rs3401440151 142 K>Q No EVA
rs3389142412 156 N>I No EVA
rs3389149578 157 K>Q No EVA
rs3389125374 176 D>N No EVA
rs3389149968 236 E>K No EVA
rs50663009 251 T>M No EVA
rs3389146959 260 R>* No EVA
rs3389149562 284 G>* No EVA
rs3389137393 305 M>I No EVA
rs3389149577 315 C>Y No EVA
rs3389113120 341 D>N No EVA
rs3389145505 398 P>Q No EVA
rs3389125359 422 V>F No EVA
rs3389149619 427 Y>N No EVA
rs3389088533 444 R>Q No EVA
rs3402058138 446 V>M No EVA
rs3389113073 467 G>S No EVA
rs3389113099 468 A>V No EVA
rs3402204083 522 K>T No EVA
rs3389149606 655 A>T No EVA
rs3389125385 676 A>V No EVA
rs3389088502 681 I>K No EVA
rs3389160967 729 Q>* No EVA
rs3389160921 750 S>* No EVA
rs26854812 804 H>Q No EVA
rs3389145519 811 D>G No EVA
rs3389154518 823 Y>C No EVA
rs3389149997 860 V>D No EVA
rs387029568 879 A>T No EVA
rs236117994 883 H>Y No EVA
rs214624146 897 C>Y No EVA
rs3389158458 929 H>Y No EVA
rs3389146984 941 A>V No EVA
rs3389122054 971 T>I No EVA
rs3389137424 1005 K>N No EVA
rs3389088480 1010 M>T No EVA
rs3389149655 1019 S>R No EVA
rs3389124707 1043 L>M No EVA
rs3389088467 1075 K>M No EVA
rs3389113102 1101 E>K No EVA
rs3389137452 1104 K>T No EVA
rs29417660 1161 A>V No EVA
rs3389160907 1188 R>Q No EVA
rs3389149960 1210 Y>* No EVA
rs3389088506 1214 N>D No EVA
rs3389088453 1220 I>K No EVA
rs3389148222 1225 K>E No EVA
rs3389149649 1225 K>I No EVA
rs3389146958 1228 D>G No EVA
rs240997656 1258 A>T No EVA
rs26836061 1322 T>I No EVA
rs256499734 1337 T>P No EVA
rs3389113118 1376 Q>* No EVA
rs253426435 1398 R>K No EVA
rs3389160963 1420 F>S No EVA
rs3389146980 1431 N>K No EVA
rs3389151993 1466 T>S No EVA
rs3389122081 1469 L>P No EVA
rs3389113069 1482 E>D No EVA
rs3389148245 1484 V>L No EVA
rs3389144142 1493 P>S No EVA
rs3389147034 1518 D>E No EVA
rs3389146993 1526 L>V No EVA
rs248629049 1544 K>Q No EVA
rs3389113088 1558 H>Y No EVA
rs3410685157 1572 I>F No EVA
rs3389160969 1590 V>M No EVA
rs3389149571 1646 S>Y No EVA
rs3389154600 1655 S>I No EVA
rs3389144197 1663 E>D No EVA
rs3389135654 1743 V>M No EVA
rs3389149989 1752 A>S No EVA
rs3402050859 1776 N>T No EVA
rs3389158515 1828 M>V No EVA

No associated diseases with Q8C3J5

4 regional properties for Q8C3J5

Type Name Position InterPro Accession
domain 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain 142 - 522 IPR002073
domain HD/PDEase domain 216 - 389 IPR003607
domain 3'5'-cyclic nucleotide phosphodiesterase N-terminal 73 - 133 IPR013706
conserved_site 3'5'-cyclic nucleotide phosphodiesterase, conserved site 259 - 270 IPR023174

Functions

Description
EC Number
Subcellular Localization
  • Endomembrane system ; Peripheral membrane protein
  • Cytoplasm, cytoskeleton
  • Colocalizes with F-actin
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytoskeleton A cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles.
endomembrane system A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

4 GO annotations of molecular function

Name Definition
GTPase activator activity Binds to and increases the activity of a GTPase, an enzyme that catalyzes the hydrolysis of GTP.
guanyl-nucleotide exchange factor activity Stimulates the exchange of GDP to GTP on a signaling GTPase, changing its conformation to its active form. Guanine nucleotide exchange factors (GEFs) act by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP), which is more abundant in the cell under normal cellular physiological conditions.
small GTPase binding Binding to a small monomeric GTPase.
T cell receptor binding Binding to a T cell receptor, the antigen-recognizing receptor on the surface of T cells.

19 GO annotations of biological process

Name Definition
actin cytoskeleton organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.
alpha-beta T cell activation The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
alpha-beta T cell proliferation The expansion of an alpha-beta T cell population by cell division.
cell migration The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
chemotaxis The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
cytoskeleton organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures.
establishment of T cell polarity The directed orientation of T cell signaling molecules and associated membrane rafts towards a chemokine gradient or a contact point with antigen presenting cell.
immunological synapse formation The formation of an area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and target cell, which facilitates activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
macropinocytosis An endocytosis process that results in the uptake of liquid material by cells from their external environment by the 'ruffling' of the cell membrane to form heterogeneously sized intracellular vesicles called macropinosomes, which can be up to 5 micrometers in size.
membrane raft polarization The clustering and aggregation of a membrane into domains. This serves as a mechanism to compartmentalize cellular activities and to establish cell polarity.
myeloid dendritic cell activation involved in immune response The change in morphology and behavior of a myeloid dendritic cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
myoblast fusion A process in which non-proliferating myoblasts fuse to existing fibers or to myotubes to form new fibers. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
negative thymic T cell selection The process of elimination of immature T cells in the thymus which react strongly with self-antigens.
positive regulation of phagocytosis Any process that activates or increases the frequency, rate or extent of phagocytosis.
positive regulation of Rac protein signal transduction Any process that activates or increases the frequency, rate or extent of Rac protein signal transduction.
positive thymic T cell selection The process of sparing immature T cells in the thymus which react with self-MHC protein complexes with low affinity levels from apoptotic death.
small GTPase mediated signal transduction The series of molecular signals in which a small monomeric GTPase relays a signal.
T cell activation The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
T cell proliferation The expansion of a T cell population by cell division. Follows T cell activation.

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9H7D0 DOCK5 Dedicator of cytokinesis protein 5 Homo sapiens (Human) PR
Q14185 DOCK1 Dedicator of cytokinesis protein 1 Homo sapiens (Human) PR
Q92608 DOCK2 Dedicator of cytokinesis protein 2 Homo sapiens (Human) PR
Q8BUR4 Dock1 Dedicator of cytokinesis protein 1 Mus musculus (Mouse) PR
Q8CIQ7 Dock3 Dedicator of cytokinesis protein 3 Mus musculus (Mouse) PR
10 20 30 40 50 60
MAPWRKTDKE RHGVAIYNFQ GSEAQHLTLQ IGDVVRIQET CGDWYRGYLI KHKLSQGIFP
70 80 90 100 110 120
TSFIHLKEVT VEKRRNIENI IPAEIPLAQE VTTTLWEWGS IWKQLYVASK KERFLQVQSM
130 140 150 160 170 180
MYDLMEWRSQ LLSGTLPKDE LKELKQKVTS KIDYGNKILE LDLIVRDEDG NILDPDKTSV
190 200 210 220 230 240
ISLFHAHEEA TYKITERIKE EMSKDQPDYG VYSRISSSPT HSLYVFVRNF VCRIGEDAEL
250 260 270 280 290 300
FMSLYDPHKQ TVISENYLVR WGSKGFPKEI EMLNNLKVVF TDLGNKDLNR DKIFLICQIV
310 320 330 340 350 360
RIGKMDLKDI NAKKCTQGLR RPFGVAVMDI TDIIKGKAES DEEKQHFIPF HPVSAENDFL
370 380 390 400 410 420
HSLLGKVIAS KGDSGGQGLW VTMKMLVGDI IQIRKDYPHL VDRTTVVARK LGFPEIIMPG
430 440 450 460 470 480
DVRNDIYITL LQGDFDKYTK TTQRNVEVIM CVCTEDGKVL PNAICVGAGD KAMNEYHSVV
490 500 510 520 530 540
YYQVKQPRWM ETVKVAVPIE DMQRIHLRFM FRHRSSLESK DKGEKNFAMS YVKLMKEDGT
550 560 570 580 590 600
TLHDGYHELV VLKGDSKKME DASAYLTLPS YRHPVENKGA TLSRSSSSVG GLSVSSRDVF
610 620 630 640 650 660
SISTLVCSTK LTQNVGLLGL LKWRMKPQLL QENLEKLKIV DGEEVVKFLQ DTLDALFNIM
670 680 690 700 710 720
MEHSQSNEYD ILVFDALIYI IGLIADRKFQ HFNTVLEAYI QQHFSATLAY KKLMTVLKTY
730 740 750 760 770 780
LDTSSRGEQC EPILRTLKAL EYVFKFIVRS RTLFSQLYEG KEQMEFEESM RRLFESINNL
790 800 810 820 830 840
MKSQYKTTIL LQVAALKYIP SVLHDVETVF DAKLLSQLLY EFYTCIPPVK LQKQKVQSMN
850 860 870 880 890 900
EIVQSNLFKK QECRDILLPV ITKELKELLE QRDDGQHQAE KKHCVELLNS ILEVLSCQDA
910 920 930 940 950 960
AFTYDHIQEI MVQLLRTVNR TVITMGRDHA LISHFVACMT AILDQMGDQH YSFYIETFQT
970 980 990 1000 1010 1020
SSDLVDFLME TFIMFKDLIG KNVYPGDWMA MSMVQNRVFL RAINKFAETM NQKFLEHTSF
1030 1040 1050 1060 1070 1080
EFQLWNNYFH LAVAFITQDS LQLEQFTHAK YNKILNKYGD MRRLIGFSIR DMWYKLGQNK
1090 1100 1110 1120 1130 1140
ICFIPGMVGP ILEMTLIPEA ELRKATIPIF FDMMLCEYQR TGAFKKFENE IILKLDHEVE
1150 1160 1170 1180 1190 1200
GGRGDEQYMQ LLESILMECT AEHPTIAKSV ENFVSLVKGL LEKLLDYRGV MTDESKDNRM
1210 1220 1230 1240 1250 1260
SCTVNLLNFY KDNNREEMYI RYLYKLRDLH LDCENYTEAA YTLLLHTWLL KWSDEQCASQ
1270 1280 1290 1300 1310 1320
VMQTGQQHPQ THRQLKETLY ETIIGYFDKG KMWEEAISLC KELAEQYEME IFDYELLSQN
1330 1340 1350 1360 1370 1380
LTQQAKFYEN IMKILRTKPD YFAVGYYGQG FPSFLRNKVF IYRGKEYERR EDFQMQLLSQ
1390 1400 1410 1420 1430 1440
FPNAEKMNTT SAPGDDVRNA PGQYIQCFTV QPVLDEHPRF KNKPVPDQII NFYKSNYVQK
1450 1460 1470 1480 1490 1500
FHYSRPVRRG KVDPENEFAS MWIERTSFLT AYKLPGILRW FEVVHMSQTT ISPLENAIET
1510 1520 1530 1540 1550 1560
MSTVNEKILM MINQYQSDES LPINPLSMLL NGIVDPAVMG GFAKYEKAFF TEEYSREHPE
1570 1580 1590 1600 1610 1620
DQDKLSHLKD LIAWQIPFLG AGIKIHEKRV SDNLRPFHDR MEECFKNLKM KVEKEYGVRE
1630 1640 1650 1660 1670 1680
MPDFEDRRVG RPRSMLRSYR QMSVISLASM HSDCSTPSKV PAESFDLESA PPKTPKVEEE
1690 1700 1710 1720 1730 1740
PISPGSTLPE VKLRRSKKRT KRSSVVFADE KAATESDLKR LSRKQEFMSD TNLSEHAAIP
1750 1760 1770 1780 1790 1800
ARVSILSQMS FASQSMPTIP ALTLSVAGVP GLDEANTSPR LSQTFFQVSD GDKKTLKKKK
1810 1820
VNQFFKTMLA SKSSEESKQI PDFLSTNM